Delex Therapeutics Inc. researches and develops drug delivery methods - specifically in pain management - called rapid onset and sustained effect delivery system. The company is seeking funds to support its research and development. A partner at a venture firm that focuses on companies in the health care and biotechnology sectors must assess the investment merits of Delex Therapeutics as it embarks on phase II clinical trials.